Background. To evaluate transitions in causes of death in patients with renal replacement therapy (RRT) since childhood over time, we performed a 10-year extension of the Late Effects of Renal Insufficiency in Children (LERIC) study. Methods. The LERIC cohort consisted of all 249 Dutch patients, who were born before 1979 and started RRT <15 years of age between 1972 and 1992. We collected data on mortality and causes of death over the period 2000-10 and compared them with the previously gathered data over the period 1972-99. Conclusions. Over the last decade, we found a substantial shift from cardiovascular disease to infections as the main
A B S T R AC T
Background. To evaluate transitions in causes of death in patients with renal replacement therapy (RRT) since childhood over time, we performed a 10-year extension of the Late Effects of Renal Insufficiency in Children (LERIC) study. Methods. The LERIC cohort consisted of all 249 Dutch patients, who were born before 1979 and started RRT <15 years of age between 1972 and 1992. We collected data on mortality and causes of death over the period 2000-10 and compared them with the previously gathered data over the period 1972-99. Results. The median duration of follow-up from the start of RRT was 25.5 (range 0.3-39.0 years). Overall, 97 patients died of whom 34 in 2000-10. The overall mortality rate and mortality rate ratios (MRRs) stabilized over time. The MRR for cardiovascular death decreased from 660 in 1972-89 to 70 in 1990-99 and to 20 in 2000-10. Conversely, the MRR for infectious death showed a U-shape; it decreased from 503 in 1972-89 to 102 in 1990-99 and increased again to 350 in 2000-10. In 2000-10, infections became the most prevalent cause of death (44%). In 2000-10, the cardiovascular mortality had decreased with 91% since 1972-89 [adjusted hazard ratio (HR): 0.09, 95% confidence interval (95% CI): 0.02-0.45, P = 0.003], while infectious mortality had doubled over time, although not significantly (adjusted HR: 2.12, 95% CI: 0.88-5.11, P = 0.09). Conclusions. Over the last decade, we found a substantial shift from cardiovascular disease to infections as the main cause of death at long-term follow-up in patients with chronic kidney disease since childhood and who were born before 1979.
I N T RO D U C T I O N
Few data exist on the very long-term outcome of patients with chronic kidney disease (CKD). Between 1998 and 2000, we conducted a comprehensive study to evaluate the Late Effects of Renal Insufficiency (LERIC) in all Dutch children who had started chronic renal replacement therapy (RRT) at <15 years of age between 1972 and 1992. Previous analyses of this cohort including data up to the year 2000 showed that, in this age category, patients with CKD had a 31-fold increased risk of mortality when compared with the general population [1] , and that cardiovascular disease was by far the most important cause of death among both the dialysis patients and transplant recipients, accounting for 41% of all deaths [1, 2] .
Our findings were confirmed by McDonald and Craig [3] , who found a similar mortality risk in patients from Australia and New Zealand who started RRT before the age of 20 years between 1962 and 2000. They found the equally high percentage of 45% of all deaths being contributed to cardiovascular disease [3] . Among the survivors in the LERIC cohort in 1999, we also found a high prevalence of cardiovascular disease, which was reflected by an overall increased mean arterial wall stiffness, left ventricular hypertrophy in 40% and aortic calcifications on ultrasound in 19% of patients [2] . In 2002, Oh et al. [4] showed similar cardiovascular abnormalities in young adults with chronic renal failure since childhood and treated with RRT, including a high prevalence of calcifying arteriopathy. Coronary calcifications were observed in 92% of patients, and carotid intimae media thickness was significantly increased compared with matched controls [4] .
Given this high prevalence of cardiovascular disease among the survivors of RRT since childhood and a possible further increase due to advancing age, we expected cardiovascular death to become an even more pronounced problem after 2000. We conducted an extended follow-up study of this cohort to investigate the actual trend in long-term mortality and causes of death after 2000.
S U B J E C T S A N D M E T H O D S

Study design
The LERIC cohort comprised all Dutch patients who had started chronic RRT at <15 years of age between 1972 and 1992, and who were born before 1979. In 1998 and 2000, the first follow-up study of these 249 patients was conducted, which was described in detail previously [1] . In 2010, a second follow-up study was conducted covering the period from the last chart review in 1999 until the last chart review in 2010-11 or the patient's death. In this paper, we analysed data on mortality and causes of death in the total cohort from 1972 until 2010 and compared two time periods, 1990 until 1999 and 2000 until 2010, with the time period 1972 until 1989. We obtained permission from the medical ethical committee and informed consent from all patients who were alive in 2000.
Data collection
For the second follow-up period, we reviewed medical charts from all patients between 1 June 2010 and 1 February 2011. We attempted to localize all emigrated patients. Among others, we collected data on the cause of death, total duration of haemodialysis (HD), peritoneal dialysis (PD) and transplantation (Tx), age at death and modality of RRT at the time of death. In living patients, the day of review was considered as the end of the observation period for that particular patient.
Categorization of causes of death
Causes of death were categorized independently by three reviewers (J.L.V., J.W.G. and K.J.J.), using detailed description of all available data around the patient's time of death. After assessment of interobserver variability, consensus was achieved by discussion. When after discussion the patient's cause of death was still unclear, the patient's nephrologist was contacted to obtain information on the cause of death. As a reference, mortality data from the Dutch general population were used, which were obtained from the Dutch Office of Death Statistics [5] .
Statistical analysis
The mortality rate (MR) was calculated as the number of deaths per 100 patient years ( pys) on RRT with a 95% confidence interval (95% CI). The mortality rate ratios (MRRs) were calculated to compare mortality in RRT patients with that in the general population. The MRR was defined as the MR for a certain cause of death in RRT patients divided by the MR in the Dutch general population for the same cause of death thereby adjusting for age and time period. We used the Cox proportional hazards model (adjusted for age and genderrelated general population mortality: background mortality) to analyse whether the risk of death for overall, cardiovascular and infectious mortalities changed over the time periods 1990-99 and 2000-10 when compared with the time period 1972-89.
R E S U LT S
Study population
The total cohort consisted of 249 patients (Table 1 ). Only 3 of the 249 patients (1.2%) were lost to follow-up. The median age at the start of RRT was 11.2 (range 1.9-15.0 years) and 54.6% were males ( Table 1 Table 1 ). Among the 231 (93%) transplant recipients, 71 (31%) lived with a single transplant-not necessarily their first -for more than 20 consecutive years and up to 37.2 years (Table 1) .
Ninety-two patients received only a single renal allograft (39.8%). Transplantation was performed two times in 84 (36.4%) patients, three times in 43 (18.6%), four times in 8 (3.5%), five times in 1 (0.4%) and six times in 3 (1.3%). Patients changed treatment modality between 1 and 11 times during the study period. Of the 249 patients, only 2 (0.8%) patients lived on a functioning graft during their entire followup (median survival 25.3 years) and 18 (7.2%) only received dialysis (median survival 3.7 years).
Of the 186 patients who were still alive in 2000, 79% had a functioning renal graft, similar to the proportion of the 152 patients who were still alive in 2010 (80%). 
Mortality and causes of death
O R I G I N A L A R T I C L E L a t e m o r t a l i t y i n p a t i e n t s w i t h R R T s i n c e c h i l d h o o d
Changes in the patterns of the cause of death Table 2 (Table 2) . We saw the same trends in MR for the different causes of death when we calculated the MR for dialysis patients and transplant recipients separately.
When we compared the mortality of RRT patients with that in the general population, the age-adjusted MRR for all causes of death decreased from 53.0 in 1972-89 to 19.7 in 1990-99, but increased again to 26.8 in the last decade (Table 2) . However, the trends over time in the MRR were different for various causes of death: the MRR for cardiovascular disease decreased significantly from 660 in 1972-89 to 70 in 1990-99 and decreased further to 20 in 2000-10. Conversely, the MRR trend for infections showed a U-shape; it decreased from 503 in 1972-89 to 102 in 1990-99 and increased again to 353 in 2000-10. The age-adjusted MRR for malignancies did not change over time. In addition, we saw the same trends in MRR for the causes of death when we calculated the MRRs for dialysis patients and transplant recipients separately. Figure 1a shows the change in the pattern of causes of death per 10-year age category and per time period. It shows a shift from cardiovascular mortality in the younger age categories (Figure 1b ) towards infectious mortality in the older age categories over time (Figure 1c and d) . Table 3 ).
After adjustment for the expected infectious background mortality, there was a borderline significant trend suggesting an increased risk of death by infections in the last decade 2000-10 when compared with 1972-89 (HR: 2.12, 95% CI: 0.88-5.11, P = 0.09; Table 3 ). The trend was, however, statistically significant when we compared infectious mortality in 2000-10 with that in 1990-99: the risk of death from infections in the last decade was more than thrice the risk in 1990-99 (HR: 3.22, 95% CI: 1.16-8.99, P = 0.03).
D I S C U S S I O N
In contrast to our expectations, we found a substantial shift from cardiovascular disease to non-cardiovascular disease as the cause of death over the last 10 years in a long-term nationwide follow-up study of patients with paediatric CKD. This occurred while the overall mortality had stabilized over time.
This study is unique in its length of follow-up of patients who started RRT in childhood. Our specific interest in the long-term follow-up of young patients unfortunately hampers the comparison with registry data that are usually presented for overall groups or older age categories with a relatively short follow-up. In addition, time may have affected mortality and causes of death in our cohort in three different fashions. First, there may be an effect of calendar time, as both mortality and causes of death may have changed over time among RRT patients as well as within the general population. Time has also led to a selection of survivors in our cohort and finally, our patients have grown older. We will discuss our results with respect to cardiovascular and infectious death in comparison with other studies, taking these three time dimensions into consideration.
Cardiovascular mortality Trends over calendar time. As cardiovascular disease turned out to be the most important cause of death in young end stage renal disease (ESRD) patients during the 1990s, several authors have highlighted the huge impact of ESRD and RRT on cardiovascular integrity and function [1, [6] [7] [8] [9] [10] ]. Yet, there are more recent data that confirm a trend of infections gradually replacing cardiovascular disease as the most important cause of death over the last decade. The United States Renal Data System (USRDS) data show a declining burden of cardiovascular mortality among the dialysis patients of all ages over the last years (MR 120/1000 per py) in 2001 to (MR 83/1000 py in 2008) [11] without changes in other causes of death over time (MR 100/1000 py in 1998, 2001 and 2008) [12] . This trend was similar in patients, aged 20-44 years, with a cardiovascular MR declining from 40.5/ 1000 py in 2001 to 31.3/1000 py in 2008 [11] . Australian and New Zealand Dialysis and Transplantation Registry (ANZDATA) also showed decreasing cardiovascular MRs for all dialysis patients (MR 9.0/100 py in 1992 to 6.4/100 py in 2005), but not among the younger patients aged 35-54 years [13] . In our study, among patients who started RRT at very young age, the decline in cardiovascular deaths over time was far more pronounced than in both the USRDS and ANZDATA studies. This difference may partially be explained by the lack of patients with diabetes mellitus in our cohort, whereas the prevalence of this disease in the RRT population with adult onset of RRT has significantly increased according to both the USRDS and ANZDATA over time. According to the USRDS data, the prevalence of diabetes mellitus as primary disease in the specific age group of our patients increased from 32.5 in 1996 to 42% in 2005, whereas the percentage of diabetes patients aged <55 years in the ANZDATA database even doubled over time from 21.9 in 1992 to 43.3% in 2005 [13, 14] . The absence of increase in cardiovascular deaths in ANZDATA cohort over time with such a concomitant substantial increase in the proportion of diabetic patients with a related severe cardiovascular burden also indicates a change in cardiovascular outcome in dialysis patients.
A possible explanation for the trend of decreased cardiovascular mortality over the last decade could be an increased awareness of the burden of cardiovascular disease in renal patients among physicians and those that may have resulted in better treatment and consequently better survival. If this would be true for our patients, it would also mean that a more aggressive treatment of cardiovascular disease and the prevention of risk factors may be beneficial even in patients who are already on dialysis or living with a functioning graft for a long time. Previous studies have shown that optimized treatment for cardiovascular comorbidity, for example, with Angiotensin-converting-enzyme inhibitors, β-blockers and angiotensin receptor blockers in patients receiving haemodialysis may indeed induce a reduction in both left ventricular hypertrophy and hypertension [15, 16] .
The decline in cardiovascular death in our population partly reflects the trend in the western general population. However, according to the MRR, the decline in our RRT patients was much more pronounced than in the general population.
Long-term follow-up and ageing. Long-term outcome data on patients with ESRD are sparse. Most studies exist on transplanted patients. Previous studies in transplanted patients showed a decrease in cardiovascular death at longer follow-up [17, 18] . The USRDS data have been analysed for all-cause, cardiovascular and infectious mortality in patients who received their first transplant at <21 years of age, between 1983 and 2006, and with a follow-up until 2006 [17] . This study showed a significant decrease in cardiovascular mortality in young transplant recipients over time [17, 18] . The risk of allcause death decreased yearly by 1% after the end of the first year of the first transplant. This decrease in risk was most pronounced for cardiovascular death (16% per year) after the end of the first year of the first transplant [17] . Using the same data, Meier-Kriesche et al. showed a progressive decrease in cardiovascular death rates in transplant recipients >18 years by renal transplant vintage. The MR decreased from 20.8/1000 py 0-3 months after transplantation to 2.8/1000 py 60+ months after transplantation [18] . These findings suggest that transplantation may halt or even reverse the progression of cardiovascular disease. Most of our patients were transplanted, so this certainly will have contributed to a decrease in cardiovascular death in our study. However, we found the same trend in reduction of cardiovascular death among dialysis patients and therefore transplantation cannot be solely responsible for the reduction of cardiovascular death. Moreover, the prevalence of risk factors for cardiovascular death, such as increased vascular stiffness, left ventricular hypertrophy and aortic valve calcification, was high among our patients in 1999, despite the fact that most of them had a long-time lasting functioning graft at that time.
In 2010, all our patients were between 30 and 50 years old. In line with what can be expected in ageing patients, the overall mortality increased over the last decade. However in contrast to that, the cardiovascular disease induced MR decreased with advancing age over the last decade. This could of course have been the result of a selection process and hence of a survivor bias; the sickest patients with cardiovascular comorbidity may have died already before 2000 of cardiovascular disease, leaving the strongest patients for the observation period after 1999. However, as mentioned before, among these survivors, there was a high prevalence of risk factors for cardiac death in 1999 [2] . Furthermore, this trend was only observed over the last decade, whereas cardiovascular mortality did increase with age in our patients, in line with the general population between 1990 and 1999.
O R I G I N A L A R T I C L E L a t e m o r t a l i t y i n p a t i e n t s w i t h R R T s i n c e c h i l d h o o d
Infectious mortality Trends over calendar time. We found a trend in infectious mortality in three different time periods that suggests an increased risk of death by infections in 2000-10 when compared with 1972-89 and 1990-99.
Infections have for a long time been found to be the second cause of death in patients with ESRD [12] . In line with our data, McDonald and Craig [3] showed a decrease of infectious mortality in patients with paediatric onset of ESRD from 39 between 1963 and 1972 to 16% between 1993 and 2002.
In contrast to our findings, the USRDS data showed a decline of infectious mortality between 1989 and 2010 in ESRD patients, aged 20-44 years. This was accompanied by a similar decline in overall mortality [22] . At the same time, there are data that confirm a more recent tendency towards increase of life-threatening infections in patients with ESRD. The USRDS showed a significant increase in hospitalization due to infection in dialysis patients from 1993 to 2005 [19] , as well as in transplanted patients between 1991 and 1998 [20] . The latter may be caused by a more intensive anti-rejection therapy of the last two decades, leading to a more impaired immunity including defective phagocytic function of granulocytes [21] . According to the UK Renal Registry, the number of deaths caused by infections in all patients on RRT has stabilized around 20% between 2000 and 2010. In contrast, the percentage of cardiac deaths decreased from 34 to 22% in this period [22] . The USRDS MRs by infection have also stabilized between 1998 and 2007 for both dialysis and transplanted patients [14] . However, all these reports have the limitation of relatively short follow-up periods.
In dialysis patients, the USRDS reported both an increase in catheter-related infections over time and in catheter-related septicaemia and an overall increasing use of catheters between 1998 and 2007 [23, 23] . In both haemodialysis and peritoneal dialysis patients, catheter-related infections are considered to be the main source of life-threatening infections, leading to peritonitis in peritoneal dialysis and to central venous lineinduced septicaemia in haemodialysis.
Our data could not be explained by the trend in the general population, in which infection plays a minor, and over time even a decreasing, role in the cause of death, at least in the western world [5, 14] .
Long-term follow-up and ageing. The USRDS data showed that infectious MR in patients who received their first transplant <21 years of age, between 1983 and 2006 and with a follow-up until 2006, did not change at follow-up [17] , suggesting that the risk was the same in the first year, as in the years thereafter. This implies that the relative contribution of infectious death has increased over time. Recurrent needle sticks of arteriovenous fistulas or grafts have also been associated with an increased risk of infections [21] . Jean et al. [24] found that a high incidence of catheter-related bacteraemia, and bacteraemic catheters were more often observed in patients with longer catheter survival time.
There are no data that support the becoming of age of our patients as a potential factor for an increased risk of fatal infections. Previously, it had been found that, in transplanted patients, very young as well as very old patients were particularly prone to dying of infections [20] . The oldest patient of our cohort was 50 years old in 2010, and very few children have been transplanted at a very young age. This may explain why we found that the risk of infectious death was constant across all age groups.
L I M I TAT I O N S
The establishment of the exact cause of death in patients with a complicated course of disease, as was often the case in our patients, can be difficult. In order to cope with this problem, three observers independently determined the cause of death based on detailed descriptions of all available chart information covering the period around the patient's time of death. After assessment of interobserver variability, consensus was achieved by discussion.
CO N C L U S I O N
In conclusion, we show that there is a substantial shift in causes of death after long-term RRT since childhood. Cardiovascular mortality decreased significantly in the last 10 years compared with the period 1972-99, and infectious mortality increased (although not significantly). A possible reason for the significant decreased risk of cardiovascular mortality could be the awareness of the cardiovascular burden in these patients that urged a strict cardiovascular management of these patients. Physicians should on the other hand be aware of the emerging burden of potentially fatal infections in these patients and take precautions for prevention.
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